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Abstract
Caspase-dependent cleavage of antigens associated with apoptotic cells plays a prominent role in the generation of CD8
+ T
cell responses in various infectious diseases. We found that the emergence of a large population of autoreactive CD8
+ T
effector cells specific for apoptotic T cell-associated self-epitopes exceeds the antiviral responses in patients with acute
hepatitis C virus infection. Importantly, they endow mixed polyfunctional type-1, type-2 and type-17 responses and
correlate with the chronic progression of infection. This evolution is related to the selection of autoreactive CD8
+ T cells with
higher T cell receptor avidity, whereas those with lower avidity undergo prompt contraction in patients who clear infection.
These findings demonstrate a previously undescribed strict link between the emergence of high frequencies of mixed
autoreactive CD8
+ T cells producing a broad array of cytokines (IFN-c, IL-17, IL-4, IL-2…) and the progression toward chronic
disease in a human model of acute infection.
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Introduction
The fate of the enormous number of apoptotic cells that derive
from effector Tcells undergoing apoptosis after performing their
functions during acute or chronic infections remain to be
determined [1,2]. Phagocytosis of apoptotic cells by dendritic cells
(DCs) leads to the processing of apoptotic cell-associated antigens
and the cross-presentation of the resulting peptides on major
histocompatibility complex (MHC) class I molecules [3–6]. This
phenomenon seems crucial for inducing either cross-priming or
cross-tolerance of CD8
+T cells, based on the presence or absence
of various infectious or danger signals influencing the switch from
tolerogenic immature (i)DCs to mature (m)DCs with high
stimulatory and migratory capacities [3–7]. In previous studies,
we found that the proteome of apoptotic T cells includes
prominent caspase-cleaved cellular proteins and that a high
proportion of distinct epitopes in these fragments (apoptotic
epitopes) can be cross-presented by DCs to a wide repertoire of
autoreactive CD8
+ T cells [8]. Recent reports have confirmed the
role of caspase cleavage in the processing and presentation of
epitopes that are derived from apoptotic cells in different models
[9–11]. In chronic HIV infection, these autoreactive CD8
+ T cells
correlate with the proportion of apoptotic CD4
+ T cells in vivo and
are involved in establishing polyclonal T cell activation that in the
long run results in generalized T cell dysfunction/depletion [8]. In
addition, apoptotic cells derived from activated T cells (in contrast
to those derived from resting T cells or from non-lymphoid cells)
retain the expression of CD40 ligand (L) and can then condition
CD40
+ DCs to acquire high capacities to prime or cross-prime
autoreactive T cells [12,13]. This mechanism is consistent with the
evidence that the signals provided by CD40L
+ apoptotic cells and
not those provided by conventional apoptotic cells facilitate the
emergence of autoreactive T cell responses to apoptotic self-
antigens [12,13].
Successful priming of naı ¨ve CD4
+ or CD8
+ T cells results in the
generation of both effector memory T (TEM) cells expressing
various differentiation programs (type-1, -2, -17), according to the
environment in which they are exposed [14–21], and central
PLoS Pathogens | www.plospathogens.org 1 June 2012 | Volume 8 | Issue 6 | e1002759memory T (TCM) cells that promptly proliferate and generate new
waves of effector cells on demand [22–24]. The transcription
factor T-box-containing protein expressed in T cells (T-bet) is the
master regulator of the type-1 cell differentiation program that is
associated with the production of IFN-c, which is required for the
development of protective immune responses against intracellular
pathogens [15]. GATA-binding protein 3 (GATA-3) controls the
development of the type-2 cell lineage that is characterized by the
production of IL-4, -5, and -13, which is critical for immunity
against helminths and other extracellular pathogens [15]. Retinoid
acid-related orphan receptor (ROR)-ct in mice and the human
ortholog RORC in humans represent the master regulators of
type-17 cell differentiation that leads to the production of IL-17,
which is specifically required for protection against several types of
extracellular and intracellular bacterial infections [14,16–18]. All
these (type-1, -2, -17) functions can elicit either protective or
harmful effects, depending on whether they are executed by
pathogen-specific or autoreactive T cells or whether the pathogen-
specific are involved during an acute resolving infection or a
chronic infection, respectively.
Here we used the hepatitis C virus (HCV) infection as a human
model of acute infection that generally undergoes chronic
progression to verify whether CD8
+ T cells that are specific for
apoptotic self-epitopes have a distinct effector type-1, -2, or -17
phenotype, to distinguish which of them is associated with the fate
of a viral infection (recovery versus chronicity), and to ascertain the
mechanisms whereby these responses are induced and maintained.
Results
Multispecificity of CD8
+ TEM cells to apoptotic epitopes
correlates with infection chronicity
We analyzed longitudinally the responses of 18HLA-A2
+
patients with acute HCV infection. The follow-up ranged from
the onset of acute disease (clinical onset) to 15–24 months (the
sixth month being considered the time of conversion from an acute
to a chronic infection). Of the 18 patients, 6 patients had a self-
limited infection and 12 patients exhibited a chronic evolution of
infection (Table 1). Initially, the effector responses were
determined by the capacity of freshly isolated CD8
+ T cells from
either HLA-A2
+ patients or healthy controls to form IFN-c spots
(in an enzyme-linked immunospot [ELISPOT] assay) within 4 to
6 hours (h) of contact with nine pools of synthetic apoptotic
peptides (Table S1A–C), eight pools of HCV genotype 1c, or
genotype 2c peptides selected for their capacity to bind the HLA-
A2 molecule [8,25], or nine pools of overlapping peptides
spanning the entire sequence of the HCV genotype 3a (Table
S2A–E). The different HCV genotype-related peptides were
matched with the viral genotype infecting the single patients.
Each peptide pool was tested in triplicate. The synthetic apoptotic
peptides used were prepared according to the sequence of caspase-
cleaved proteins that had been previously identified by the
proteomic analyses of apoptotic T cells (i.e., fragments of actin
cytoplasmic 1 [ACTB], heterogeneous nuclear ribonucleo protein
[ROK], lamin B1 [LAM1], non muscle myosin heavy chain 9
[MYH9], vimentin [VIME], or proteasome component C2
[PSA1]) [8]. We found that the apoptotic (but not the viral)
epitope repertoire recognized by IFN-c
+CD8
+ TEM cells was
significantly larger in patients undergoing chronic infection than in
those undergoing recovery (Fig. 1A,B and Fig. S1). Interestingly,
the mean number of IFN-c spots promptly formed by CD8
+ TEM
cells in response to each pool of apoptotic epitopes (but not viral
epitopes) was directly correlated with the viral (plasma HCV-
RNA) load, thus supporting the relationship between these
responses and chronic evolution (Fig. 1C). None of the 21
HLA-A2
+ healthy donors exhibited significant effector responses
against any of the apoptotic or viral peptides ex vivo (data not
shown). The HLA-restriction of these responses was demonstrated
both by blocking responses with an appropriate anti-class I mAb
and by determining that no response was observed in HLA-A2
2
patients (data not shown).
Mixed polyfunctional apoptotic epitope-specific CD8
+ T
cells in chronic HCV evolution
We enumerated specific CD8
+ T cells directly in the peripheral
blood of HLA-A2
+patients or healthy donors by using pentamers
of HLA-A*0201 molecules complexed to either apoptotic
(MYH9478–486, MYH9741–749, VIME78–87) or viral epitopes
Author Summary
The emergence of a large population of mixed polyfunc-
tional (type-1, -2, -17) CD8
+ T cell effector responses
specific for apoptotic T cell-associated self-epitopes rather
than the dysfunction or altered quality of virus-specific
CD8
+ T cells is associated with the progression toward
chronic disease in the human model of acute HCV
infection. The chronic evolution is associated with the
selection of autoreactive CD8
+ T cells with higher T cell
receptor avidity, whereas those with lower avidity undergo
prompt contraction, as seen in patients undergoing
infection resolution. We suggest that these autoreactive
responses are secondary to the viral persistence and can
participate to the HCV-related immunopathology. This
data has implications for the prognosis and therapy of
infections undergoing chronic evolution.
Table 1. Clinical parameters of patients with acute HCV
infection.
Pt Genotype Outcome
ALT
(U/ml)
HCV-RNA
(copies/ml)
1C 1b Chronic 88 556000
2C 2a/2c Chronic 695 3310
3C 3a Chronic 1113 156000
4C 2a/2c Chronic 600 915000
5C 1b Chronic 227 600
6C 3a Chronic 131 940000
7C 1b Chronic 481 462000
8C 3a Chronic 650 900000
9C 1a Chronic 940 500000
10C 3a Chronic 403 919000
11C 1b Chronic 1200 640000
12C 1b Chronic 1320 490000
1S 1b Self-limited 2710 106000
2S 3a Self-limited 1967 2120
3S 2a/2c Self-limited 285 361000
4S 1a Self-limited 1359 96100
5S 1b Self-limited 2860 210200
6S 1b Self-limited 2650 69500
Pt, patient; ALT, serum alanine aminotransferase (n.v., 0–40 U/ml).
doi:10.1371/journal.ppat.1002759.t001
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PLoS Pathogens | www.plospathogens.org 2 June 2012 | Volume 8 | Issue 6 | e1002759Figure 1. CD8
+ T cell multispecificity to apoptotic epitopes in chronic HCV progression. (A,B) Mean number of spot-forming cells (SFCs)
by fresh CD8
+ T effector memory (TEM) cells (by ELISPOT assay) in response to pools (see Tables S1A–C and S2A–E) of apoptotic self-epitopes (A) or
viral epitopes (B) in HLA-A2
+ patients with acute HCV infection experiencing chronic infection (filled circles) or undergoing infection resolution
(empty circles), evaluated at different time points of the infection. Each peptide pool contained 5 mg/ml each single peptide. Each circle represents a
single patient. NS=not significant. (C) Representative correlation (6
th month after clinical onset) between the mean number of SFCs formed by fresh
CD8
+ TEM cells in response to pools of apoptotic self-epitopes and the viral load (HCV-RNA copies/ml) in patients experiencing chronic infection or
undergoing infection resolution. Statistical analysis was performed using non-parametric Spearman’s test. (D) Representative flow cytometry analyses
of PBMCs from a HLA-A2
+ patient (Pt.) or a HLA-A2
+ healthy donor (H.D.). Cells were then double-stained with a monoclonal antibody (mAb) to CD8
and pentamers expressing the indicated peptides of MYH9, VIME, HCV-NS3, or HCV-Core. Counterplot analyses show the percentage of
CD8
+pentamer
+ cells. The percentage of cells is indicated in each quadrant. (E,F) Percentages of CD8
+pentamer
+ cells from20 HLA-A2
+ H.D. and all
HLA-A2
+ patients studied (filled and empty symbols represent patients experiencing chronic infection or undergoing infection resolution,
respectively) evaluated at different time points. In the panel E, circle symbols representMYH9478–485 pentamer specificity, square symbols represent
MYH9741–749 pentamer specificity, and triangle symbols represent VIME78–87 pentamer specificity. In the panel F, circle symbols represent HCV-
NS31073–1081 pentamer specificity, square symbols represent HCV-NS31406–1415 pentamer specificity, and triangle symbols represent HCV-Core132–140
pentamer specificity. NS=not significant. *The percentages of both apoptotic epitope- and viral epitope-specific CD8
+pentamer
+ cells from H.D.
were significantly lower than those from patients (in any time point tested) (p,0.0001).
doi:10.1371/journal.ppat.1002759.g001
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identified as the most immunogenic among all patients tested
(Fig. 1D). Control HLA-A*0201 pentamers complexed to a non-
natural irrelevant peptide were unable to stain CD8
+ T cells in all
peripheral blood mononuclear cells (PBMCs) tested (data not
shown). The pentamer values were significantly higher in both in
patients experiencing chronic infection and in patients with self-
limited infection (at all the time points tested) than in 20 HLA-A2
+
healthy donors (Fig. 1E,F). However, in contrast to the ELISPOT
assay showing frequencies of IFN-c
+CD8
+Tcells specific to
apoptotic peptides significantly higher in patients experiencing
chronic infection than in patients with self-limited infection
(Fig. 1A), the total frequencies of either apoptotic or viral
epitope-specific CD8
+ T cells, as detected by pentamers, did not
differ between patients undergoing chronic or recovery evolution
at all the time points tested (Fig. 1D–F). This difference may be
explained by the finding that each single pentamer
+ cell
population can simultaneously contain (rare) naı ¨ve T cells, many
TCM cells and several types of TEM cells with the same epitope
specificity, as well as T cells with a ‘‘stunned phenotype’’
(representing the reducing capacity of cells to perform effector
functions) [26], whereas ELISPOT assay only identifies IFN-c+
cells in our system. To detect different effector functions within the
CD8
+pentamer
+ T cells, we analyzed the frequencies of freshly
isolated CD8
+pentamer
+ T cells that produced a wide array of
cytokines (IL-17, IFN-c IL-4, IL-2 within a few h of contact with
the relevant peptides and optimal concentrations of anti-CD28
mAb, which served as a surrogate costimulatory signal. Irrelevant
cytokine production was observed when either apoptotic epitope-
or viral epitope-specific CD8
+pentamer
+ T cells of 20 HLA-A2
+
healthy individuals were stimulated with this procedure (data not
shown). Importantly, apoptotic epitope-specific CD8
+pentamer
+
TEM cells promptly produced notable and sustained amounts of all
the cytokines tested within a few h of contact with the relevant
epitopes, much more in patients experiencing chronic infection
than in those undergoing infection resolution (Fig. 2A,B), in all
time points tested (Fig. S2). By contrast, the virus-specific
CD8
+pentamer
+ TEM cells produced lower amounts of the same
cytokine in both categories of patients without any differences
between them(Fig. 2A,B and Fig.S3). Peptide dose-response
curves of cytokine-producing CD8
+pentamer
+ cells emphasized
this difference (Fig. 2C,D). Time course analyses, performed
longitudinally throughout the follow-up in all patients, revealed
that the frequencies of polyfunctional apoptotic epitope-specific
CD8
+ TEM cells were significantly higher in patients experiencing
chronic infection (Fig. 3A,B). These responses were sustained
over time in relation to the sustained viral load (HCV-RNA copies)
and alanineaminotransferase (ALT) levels only in patients who
evolved into chronic infection (Fig. 3A,B). Then, the majority of
these cell frequencies, as well as the serum biomarkers of viral
hepatitis, tended to decline considerably later in patients who
evolved into chronic infection than in those resolving infection
(Fig. 3A,B). By contrast, no substantial difference was revealed in
the time course of the virus-specific effector response between the
two categories of patients (Fig. 3C, Fig. S3). Notably, the
polyfunctional responses in the majority of patients were
maintained by the parallel presence of different antigen-specific
CD8
+ T cell subsets, each of which produced a single cytokine in
all time-points tested (mixed polyfunctional populations) (Fig.-
S4A,B). Therefore, the minority of patients showed cells
simultaneously producing significant amounts of IFN-c and IL-
17 (type 1/17 cells), or cells simultaneously producing significant
amounts of IL-17 and IL-4 (type 2/17 cells) (Fig. 2A,B and Fig.
S4A,B). Importantly, the frequencies of CD8
+pentamer
+ TEM
cells promptly producing IFN-c or IL-17 in response to the
relevant apoptotic epitopes, but not to the viral epitopes (data not
shown), were directly correlated with the plasma viral load or the
serum ALT levels(Fig. 4A–D).
Cross-presentation of apoptotic T cells ex vivo
Fresh apoptotic epitope-specific CD8
+pentamer
+ TEM cells
promptly produced IFN-c or IL-17 ex vivo within a few h of contact
with DCs that had been pulsed with apoptotic T cells (i.e., through
the cross-presentation mechanism) (Fig. 5A,B). The cross-
presentation resulted in a marked decrease in IFN-c or IL-17
production when apoptotic cells had been previously treated with
a selective caspase-3 inhibitor (C3I) (Fig. 5A,B). This phenom-
enon was confirmed in five independent patients (Fig. 5B). DCs
alone, despite known to endogenously express high levels of the
ubiquitous (long-lived) cellular proteins (vimentin, non-muscle
myosin, actin, heterogeneous nuclear ribonucleoprotein, lamin
B1…) (14),were unable to directly stimulate the related specific
CD8
+ T cells (Fig. 5A,B).The frequencies of apoptotic epitope-
specific CD8
+ T cells (but not those of viral epitope-specific CD8
+
T cells [data not shown]) correlated with the number of circulating
apoptotic T cells (Fig. 5C).The percentage of apoptotic T cells in
PBMCs was significantly higher in patients than in the 20 healthy
donors tested (11.067.7 versus 3.963.9; P,.001).
Flexibility of type-17 CD8
+ TEM cell responses to
apoptotic epitopes
To verify if type-17 CD8
+ TEM cells specific to apoptotic self-
antigens in the long run acquire functional plasticity in vivo
[15,18,27–29], we monitored (from the clinical onset of infection
up to 24 months) selected patients showing a notable number of
CD8
+ TEM cells promptly producing IL-17 within few h of contact
with the relevant apoptotic epitopes at the clinical onset. During
the course of the follow-up, the frequency of type-17 CD8
+ TEM
cells exhibited a progressive increase, followed by the emergence
of type-1/17 cells in response to apoptotic epitopes (Fig. 6A).
These responses were associated with both the maintenance of the
type-17 transcription factor RORC and the appearance of the
type-1 transcription factor T-bet (Fig. 6B,C). This scenario was
observed both in the 3 patients showing type-17 CD8
+ TEM cells
specific for the MYH9741–749 epitope (Fig. 6), and in additional 3
patients showing type-17 CD8
+ TEM cells specific for different self-
epitopes epitope (data not shown). By contrast, representative fully
polarized type-1 CD8
+ TEM cells strictly maintained this
phenotype throughout the follow-up period in all patients studied
(Fig. S5online). To determine whether antigen-specific type-17
CD8
+ T cells can reprogram their phenotype and convert into
type-1/17 CD8
+ TEM cells in vitro(situation which may mimic the
type-17 conversion into type-1/17 phenotype in vivo), we used anti-
CCR6 and anti-CCR4 mAbs [30] to sort IL-17–producing cells
from antigen-stimulated CD8
+ T cells (purity .98% type-17
pentamer
+CD8
+ T cells) (Fig. 6D). These cells were then
restimulated in vitro with irradiated autologous PBMCs (acting as
antigen-presenting cells [APCs]) that had previously been pulsed
with the relevant peptide in the presence of either a mixture of
IFN-c and IL-12 (polarizing toward the type-1 phenotype) or a
mixture of TGF-b, IL-6, IL-23, and IL-1b (polarizing toward the
type-17 phenotype) [14,31]. After 10–12 days of culture in IL-2
conditioned medium, the cells were tested for their capacity to
produce both IL-17 and IFN-c in response to the peptide plus
APCs. Interestingly, CD8
+ T cells that had been cultured in the
presence of the type-17 polarizing cytokines maintained or
increased the original type-17 phenotype, whereas CD8
+ T cells
that had been cultured in the presence of the type-1 polarizing
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+ TEM cells specific to apoptotic epitopes distinguish patients experiencing chronic infection. (A,B)
Representative flow cytometry analyses of PBMCs from patients with acute HCV infection experiencing chronic infection (A) or undergoing infection
resolution (B) that were stained with mAb to CD8 and pentamers complexed to the indicated apoptotic or viral epitopes. Cells were then stimulated
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phenotype (Fig. 6D).
Polyfunctional autoreactive CD8
+ T cells are modulated
by PD-1
To understand why the self-epitope-specific cells of patients
undergoing resolution display significantly lower polyfunctional
functions than patients experiencing chronic infection (Fig. 2A–D
and Fig. 3A,B), we performed a series of functional experiments.
First, we ruled out the possibility that apoptotic epitope-specific
CD8
+ T cells from patients undergoing recovery expressed
intrinsic defects of effector cell functions. Indeed, apoptotic
epitope-specific CD8
+ T cells from the two categories of patients
yielded similar cytokine responses after stimulation by polyclonal
mitogens (i.e., phorbol 12-myristate 13-acetate [PMA] and
ionomycin [iono]) (Fig. S6). Second, the majority of CD8
+penta-
mer
+ T cells (both apoptotic epitope-specific and viral epitope-
specific) in both categories of patients were either
with the relevant soluble peptides plus anti-CD28 mAb and processed for the detection of IL-17, IL-22, IFN-c, IL-4, and IL-2 by ICS assay with the
relevant mAbs. Counterplot analyses are gated on CD8
+pentamer
+ cells and show percentages of cytokine-producing cells. The percentage of cells is
reported in each quadrant. The small histograms show ICS analyses of representative cytokine (IL-17, IL-22, IFN-c, IL-4, or IL-2) production without
antigenic stimulation by gated CD8
+pentamer
+ cells. (C,D) Peptide dose-response curves of cytokine-producing CD8
+pentamer
+ cells from patients
with acute HCV infection experiencing chronic infection (C) or undergoing infection resolution (D). Cells were stained with the pentamers expressing
the indicated peptides and stimulated for 6 h with the same soluble peptides. They were then processed for the detection of the different cytokines
indicated by ICS assay. Values are shown with the background subtracted.
doi:10.1371/journal.ppat.1002759.g002
Figure 3. Polyfunctional CD8
+ TEM cells specific to apoptotic epitopes correlate with the chronic progression of HCV infection. (A)
Kinetics of plasma HCV-RNA and ALT levels until 15–24 months from clinical onset of infection. Each symbol represents a single patient. Patients
resolved: patients with acute HCV infection undergoing infection resolution; Patients chronic: patients with acute HCV infection undergoing chronic
infection. (B) Kinetics of the means of all the CD8
+pentamer
+ (pent) cells specific to MYH9478–485, MYH9741–749, or VIME78–87 epitopes promptly
producing the indicated cytokines in response to the relevant apoptotic epitopes. (C) Kinetics of the means of all the CD8
+pentamer
+ (pent) cells
specific to HCV-NS31073–1081, HCV-NS31406–1415, or HCV-Core132–140 epitopes promptly producing the indicated cytokines in response to the relevant
viral epitopes. The cells were calculated as percentage of cells expressing CD8, pentamer ligands, and cytokines in PBMCs. Values are shown with the
background subtracted. Filled circles represent patients with acute HCV infection experiencing chronic infection; empty circles represent acute HCV-
patients undergoing infection resolution.
doi:10.1371/journal.ppat.1002759.g003
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+CD127
+ (TCM cells) or CD45RO
+CD127
2 (TEM cells)
(Fig. S7A,B). This finding suggested that the CD127
2CD8
+ TEM
cells, which promptly produced the vast array of cytokines tested
within a few hours of contact with the relevant peptides (Fig.
S7C), were likely derived from the CD8
+ TCM cells rather than
naı ¨ve cells in both categories of patients in vivo.
Then, we evaluated whether the apoptotic epitope-specific
CD8
+ TEM cells were less polyfunctional in patients undergoing
infection resolution because they were conditioned by a more
severe programmed death (PD)-1-dependent exhaustion [32] in
comparison to those from patients experiencing chronic infection.
We found a similar PD-1 expression in apoptotic epitope-specific
CD8
+ T cells between patients undergoing infection resolution and
those experiencing chronic infection (Fig. S8A).This result might
argue against the possibility of a more severe PD-1-dependent
exhaustion of apoptotic epitope-specific CD8
+ TEM cells from
patients resolving infection. However, we cannot exclude that the
two groups of patients might express different levels of PD-1
ligands (i.e., in inflamed liver) that might provide different
threshold of PD-1 dependent exhaustion in vivo. PD-1 upregulation
was also shown in HCV-specific CD8
+ T cells without any
significant difference between the two categories of patients (Fig.
S8B). To determine the functional capacity of PD-1 expression,
we first selected PBMCs containing either viral epitope-specific
PD-1
+CD8
+ T cells or apoptotic epitope-specific PD-1
+CD8
+ T
cells from patients undergoing infection resolution or those
experiencing chronic infection. In the presence or absence of a
blocking anti-PD-L1 mAb or isotype control mAb in vitro, these
cells were stimulated with the relevant peptide and anti-CD28.
After 10 days of culture in IL-2-conditioned medium, cells were
double-stained with the appropriate pentamers and anti-CD8
mAb, stimulated or not with autologous APCs plus the peptide,
processed for intracellular cytokine staining (ICS) with mAbs to
IFN-c, IL-17, and IL-4, and analyzed by flow cytometry.
Apoptotic epitope-specific pentamer
+CD8
+ T cells produced
notable amounts ofIFN-c or IL-4 after 10 d of stimulation, and
even more in the presence of a blocking anti-PD-L1 mAb
(Fig. 7A). By contrast, IL-17 production under the same
conditions failed to increase but rather decreased during the
10 d of antigen stimulation in vitro, irrespective of the presence of
Figure 4. CD8
+pentamer
+ TEM cells producing IFN-c or IL-17 in response to apoptotic epitopes correlate with clinical parameters.
(A,B) Correlation between the viral load (HCV-RNA copies) and CD8
+pentamer
+ TEM cells producing IFN-c (A) or IL-17 (B) in response to apoptotic
epitopes in patients with acute HCV infection experiencing chronic infection or infection resolution. (C,D)Correlation between ALT and
CD8
+pentamer
+ TEM cells producing IFN-c(C) or IL-17 (D) in response to apoptotic epitopes in patients with acute HCV infection experiencing chronic
infection or infection resolution.
doi:10.1371/journal.ppat.1002759.g004
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cell population (Fig. 7A). Cumulative experiments with PBMCs
from a total of eight patients confirmed that the PD-1/PD-L1
blockade resulted in an increase of IFN-c or IL-4 production by
both apoptotic epitope-specific pentamer
+CD8
+ T cells (Fig. 7B)
and viral epitope-specific pentamer
+CD8
+ T cells (data not
shown), whereas the production of IL-17 was not affected.
Importantly, the degree of increase in the responses exhibited by
both apoptotic epitope-specific pentamer
+CD8
+ Tc e l l sa n dv i r a l
epitope-specific pentamer
+CD8
+ T cells was virtually the same
between patients undergoing infection resolution and those
evolving into chronic infection (data not shown). Taken together,
these findings suggest the following. First, the apoptotic epitope-
specific PD-1
+CD8
+ T cell responses are gently modulated by
PD-1 because they are highly polyfunctional in patients
experiencing chronic infection ex vivo. Second, the PD-1 blockade
does not seem a principal cause of the decreased responsiveness
exhibited by apoptotic epitope-specific CD8
+ T cells from
patients undergoing infection resolution in comparison to
responses from patients who have developed a chronic infection,
given that the degree of increase in the effector responses upon
PD-1/PD-L1 blockade was very similar between the two
categories of patients. However, we cannot exclude that other
PD-1 ligands or the differential PD-L1 expression by inflamed
liver can intervene in favoring T cell exhaustion or dysfunction in
vivo, thus explaining the decreased responsiveness exhibited by
apoptotic epitope-specific CD8
+ T cells from patients undergoing
infection resolution [33].
Figure 5. CD8
+ TEM cells specific to apoptotic epitopes are activated by apoptotic epitopes naturally processed and cross-presented
by DCs. (A) One representative of five experiments in which PBMCs from one patient with acute HCV infection were double-stained with mAb to
CD8 and pentamers complexed with the indicated apoptotic epitope, and cultured with autologous DCs that had been pulsed or not with the
relevant soluble peptide, apoptotic cloned T cells (ACs=apoptotic cells), ACs previously treated with a negative caspase control (K=Z-FA-FMK), or
ACs previously treated with the caspase 3 inhibitor (C3I=z-devd-fmk). After 6 h, CD8
+pentamer
+ cells were tested for their capacity to produce the
different cytokines indicated by the ICS assay. Counterplots are gated on CD8
+pentamer
+ cells and show percentages of the different cytokine-
producing cells in each quadrant. (B) Cumulative experiments in 5 independent patients, performed as described in (A), showing the percentages of
cells producing the indicated cytokines in CD8
+pentamer
+ cells in response to the following stimuli: autologous DCs alone (a); DCs that had been
pulsed with the MYH9741–749 peptide (b); DCs that had been pulsed with ACs, previously treated with a negative caspase control (Z-FA-FMK) (c); or
DCs that had been pulsed with ACs previously treated with the caspase 3 inhibitor (Z-DEVD-FMK) (d). Each symbol represents a single patient. (C)
Correlation (analysed at the 15
th month after clinical onset) between the percentage of CD8
+pentamer
+ cells specific to apoptotic epitopes and the
percentage of circulating apoptotic T cells in patients with acute HCV infection experiencing chronic infection (filled circles) or infection resolution
(empty circles). Statistical analysis was performed using non-parametric Spearman’s test.
doi:10.1371/journal.ppat.1002759.g005
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+ T
cells to infection outcome
Finally, we hypothesized that differences in T cell receptor
(TCR) avidity might account for the different apoptotic epitope-
specific CD8
+ T cell responsiveness between patients experiencing
chronic infection and those undergoing infection resolution. To
assess TCR avidity, we evaluated the dissociation kinetics of
peptide/HLA-A*0201 pentamer binding to antigen-specific CD8
+
T cells that were isolated from the two groups of patients [34].
Specifically, we stained fresh CD8
+ T cells with saturating
amounts of HLA-A*0201 pentamers that were complexed to
either apoptotic or viral epitopes and an anti-CD8 mAb for
45 min at room temperature. Cells were then washed and
incubated at 4uC with saturating amounts of an anti-HLA-A2
mAb to prevent rebinding of pentamers during the pentamer
dissociation assay. The rate of decay was measured by flow
cytometry at appropriate time points. We obtained linear decay
plots of the natural logarithm of the normalized fluorescence
versus time in all experiments performed, indicating that the
pentamer decay was occurring stochastically and that the resulting
pentamer staining half-lives(t1/2) should be proportional to the t1/2
of respective pentamer/TCR complexes (Fig. 8A). The t1/2 for
Figure 6. Functional flexibility of fresh IL-17–producing CD8
+ T cells specific to apoptotic epitopes. (A) PBMCs from three independent
patients with acute HCV infection were stained with mAb to CD8 and pentamers complexed with the indicated apoptotic peptide. Cells were
stimulated with the relevant soluble peptide plus anti-CD28 mAb for 6 h and then processed for the detection of IL-17 and IFN-c by ICS assay with
the relevant mAbs. Counterplot analyses are gated on CD8
+pentamer
+ cells and show percentages of cytokine-producing cells. The percentage of
cells is reported in each quadrant. The small histograms show ICS analyses of representative cytokine (IL-17, or IFN-c) production without antigenic
stimulation by gated CD8
+pentamer
+ cells. (B) Representative flow cytometry analysis in which cells were stimulated as previously described and
processed for the detection of IL-17, IFN-c, RORC, and T-bet by ICS assay with the relevant mAbs. Analysis gated on CD8
+pentamer
+IL-17
+ IFN-c
+ cells
(signed by the star symbol in the panel A) show percentages of RORC- and Tbet-expressing cells. The percentage of cells is reported in each quadrant.
(C) Mean percentages of RORC
+ or T-bet
+ cells detected in all the timely followed CD8
+pentamer
+ cells producing IL-17 or IFN-c upon antigen
stimulation. (D)IL-17–producing CD8
+ T cells specific to apoptotic epitopes efficiently convert to IFN-c producing cells in vitro. One representative of
three experiments in which PBMCs from patients with acute HCV infection were stained with mAb to CD8 and pentamers complexed with the
indicated apoptotic peptide, stimulated with the relevant soluble peptide plus anti-CD28 mAb for 6 h, and processed for the detection of IL-17 and
IFN-c by ICS assay with the relevant mAbs. Counterplot analyses are gated on CD8
+pentamer
+ cells and show percentages of cytokine-producing
cells. The percentage of cells is reported in each quadrant. Cells producing IL-17 were sorted by using anti-CCR6 and anti-CCR4 mAbs and FACSAria
processing (the purity of IL-17
+ cell population was evaluated by stimulating CCR6
+CCR4
+ cells with anti-CD3 and anti-CD28 mAbs). CCR6
+CCR4
+ cells
were re-stimulated with the same apoptotic epitope and autologous APCs in the presence or absence of either the cytokine mixture type-17 (IL-1b, IL-
6, IL-23 and TGF-b) polarizing toward the type-17 cell phenotype or the cytokine mixture type-1 (IFN-c and IL-12) polarizing toward the type-1 cell
phenotype. After 10–12 d of culture in IL-2 conditioned medium, cells were stained with pentamers expressing MYH9741–749 peptide, further antigen-
stimulated as previously described, and tested for their capacity to produce IL-17 and IFN-c by ICS assay.
doi:10.1371/journal.ppat.1002759.g006
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+ T
cells from patients experiencing chronic infection was significantly
longer than the decay of pentamer staining to CD8
+ T cells from
patients undergoing infection resolution (Fig. 8A,B). By contrast,
the t1/2 for viral epitope-complexed pentamers to CD8
+ T cells did
not differ between patients experiencing chronic infection and
Figure 7. Tuning of apoptotic epitope-specific CD8
+ T cells by PD-1. (A) Representative experiment in which PBMCs from a patient with
acute HCV infection were stained with mAb to CD8 and the pentamer complexed with the indicated apoptotic epitope. Cells were then stimulated
with the soluble form of the indicated peptide and anti-CD28 mAb in the presence or absence of a blocking antibody to PD-L1 or an isotype control.
After 6 h and 10 d of culture, cells were processed for the detection of the indicated cytokines by ICS assay with the relevant mAbs. (B) Cumulative
experiments, performed as described in (a), showing the percentages of cells producing the indicated cytokines in CD8
+pentamer
+ cells, evaluated at
different time points from the stimulation with the apoptotic peptides in the presence or absence of mAb to PD-L1. NS=not significant.
doi:10.1371/journal.ppat.1002759.g007
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experiments in which HLA-A*0201 pentamers were complexed
to a non-natural irrelevant peptide showed that the t1/2 for staining
to CD8
+ T cells was undetectable (data not shown).
Discussion
Here we demonstrate for the first time that the multispecificity,
magnitude, and polyfunctional (type-1, -2, -17)strength of CD8
+
TEM cell responses directed to apoptotic self-epitopes were wide
and robust during the acute phase of HCV infection, particularly
in patients experiencing chronic progression compared with those
undergoing infection resolution. The responses were directly
correlated with the plasma viral load, the serum ALT levels or
the number of circulating apoptotic T cells, and were then
sustained over time in relation to the viral persistence. Our parallel
study still in progress indicates that similar autoreactive CD8
+ T
cell responses in chronically infected patients are recruited in the
inflamed livers (Fig. S9), are related with the signs of hepatic
damage, and decrease in relation with the decline or the
disappearance of the viral load upon antiviral therapy (interferon
plus ribavirin
@) (data not shown). Altogether these results suggest
that strong CD8
+ T cell responses against apoptotic self-epitopes
arise and are maintained in HCV infection and may potentially
contribute to the liver immunopathology through the production
of high levels of inflammatory cytokines.
Recently, several models of chronic viral infection demonstrated
that virus-specific CD4
+ or CD8
+ T cells producing elevated levels
of IL-17 correlated with either viral persistence or a wasting
syndrome with a multiple organ neutrophil infiltration [20,35,36].
Currently, our data suggest that the emergence of high frequencies
of mixed autoreactive CD8
+ T cells producing a broad array of
cytokines (including IL-17) is prominent in patients undergoing
chronic progression in the human model of acute HCV infection.
By contrast, the frequencies of virus-specific effector cells
(producing the different cytokines analyzed) were extremely low
as compared with the apoptotic epitope-specific. Our data are
coherent with the majority of studies revealing that the magnitude
of HCV-specific CD8
+ T cell effector responses does not correlate
with the clinical or viral outcome in acute HCV infection [37]. In
particular, HCV-specific CD8 T cells have been reported to
express increased levels of PD-1 and an exhausted phenotype
(weak proliferation, IFN-c production, and cytotoxicity) [37–
41].Although depletion studies in the chimpanzee model are
consistent with a role of CD8
+T cells as primary effector of
protective immunity [42], studies in natural HCV infection were
unable to find clear correlations between HCV-specific CD8
+ T
cell responsiveness and outcome of infection [37–41,43,44]. It is
possible that the mechanisms that control HCV in the long term
lie not exclusively on these conventional functions, but they are
also displayed by some other subset of immune mediators,
including HCV-specific antibodies [45]or CD4
+ T cells
[26,40,46].Consistent with this finding, in vivo depletion of CD4
+
T cells from HCV-recovered chimpanzees abrogates protective
CD8
+ T cell–mediated immunity upon rechallenge [47], which
suggests that CD4
+ T cell help is required for the generation and
maintenance of protective CD8
+ T cells. Therefore, the viral
immunological correlates of infection should be detected by
multiparametric analyses (antibody, CD4
+, CD8
+ responses…)
rather than individual analysis that may underestimate the
multiple immunological variables related to infection outcome.
In this respect, our study suggests that the apoptotic epitope- more
than the virus-specific CD8
+ cell responses discriminate patients
with different infection outcome.
The observation that cross-presentation of apoptotic T cells by
DCs requires caspase-dependent cleavage of apoptotic self-
antigens to promptly activates specific CD8
+ TEM cells ex vivo
indicates that this mechanism might be operative in the induction
of the related polyfunctional autoreactive responses in vivo. This
possibility is emphasized by the finding that the frequencies of
apoptotic epitope-specific CD8
+ T cells correlated with the
number of circulating apoptotic T cells. Consistently with our
previous observations (14), cross-presentation of apoptotic cells
Figure 8. Decay kinetics of pentamer staining for CD8
+ T cells.
(A) Representative decay plot of the natural logarithm of the
normalized fluorescence versus time after anti-HLA-A2 mAb addition
for fresh PBMCs stained with pentamers that were complexed with the
indicated apoptotic epitope. The t1/2 represents the staining half-times
for the pentamers to CD8
+ T cells. Filled or empty circles represent
PBMCs from patients with acute HCV infection experiencing chronic
infection or undergoing infection resolution, respectively. (B) The t1/2
for the pentamers (complexed with apoptotic or viral epitopes) binding
CD8
+ T cells from patients with acute HCV infection experiencing
chronic infection (filled symbols) or undergoing infection resolution
(empty symbols). Apoptotic epitopes: circle symbols represent the
MYH9478–485 pentamer specificity, square symbols represent MYH9741–
749 pentamer specificity, and triangle symbols represent VIME78–87
pentamer specificity. Viral epitopes: circle symbols represent HCV-
NS31073–1081 pentamer specificity, square symbols represent HCV-
NS31406–1415 pentamer specificity, and triangle symbols represent
HCV-Core132–140 pentamer specificity.
doi:10.1371/journal.ppat.1002759.g008
Autoreactive CD8+ T Cells in HCV Infection
PLoS Pathogens | www.plospathogens.org 11 June 2012 | Volume 8 | Issue 6 | e1002759plays a key role in activating autoreactive CD8
+ T cells, as
caspase-dependent cleavage of cell-associated (long-lived) proteins
(such as vimentin, non-muscle myosin, actin, heterogeneous
nuclear ribonucleoprotein, lamin B1…) is required to efficiently
target the related fragments to the processing machinery of DCs.
By contrast, live DCs alone, despite known to express the whole
form of the same ubiquitous (long-lived) cellular proteins(14), are
unable to stimulate the related specific CD8
+ T cells by direct
presentation mechanism, likely because they do not possess the
caspase-cleavage program required for the presentation of these
proteins (14).Collectively, these data suggest that these autoreac-
tive CD8
+ T cells may perform their functions through the by-
stander effect of the pro-inflammatory cytokines upon cross-
presentation of apoptotic cells rather than by the direct killing of
cells endogenously expressing the related self-antigens. The strong
production of IFN-c and IL-17 may favor the triggering of
recruitment of inflammatory cells, which contribute to the
immunopathology [48–50].Our study provides a possible expla-
nation for why the enormous expansion of activated T cells,
during persisting viral infections, is only minimally attributable to
virus-specific T cells [8]. Inflamed tissues (including the HCV-
infected liver) are generally infiltrated by several billions of
activated lymphocytes and the rate of apoptotic cells derived from
them by far exceeds that originated by the turn-over of epithelial
cells (i.e., hepatocytes) [51]. The demonstration that apoptotic cells
derived from activated T cells (in contrast to those derived from
epithelial cells) are CD40L
+ and then condition CD40
+ DCs to
prime T cells [12,13], suggest that they are the most important
source of apoptotic self-antigens capable to cross-prime CD8
+ T
cell responses in an inflamed microenvironment. However, we
cannot exclude that also apoptotic hepatocytes may amplify this
phenomenon in an inflammatory context, because they might
potentially generate the same caspase-cleaved antigenic fragments
described in apoptotic T cells [8], and be cross-presented by DCs.
Recent data have clearly stressed the importance of infections
in inducing and maintaining autoimmunity [52]. In particular,
the initial emergence of apoptotic antigen-specific T cells in acute
HCV infection may be dependent on virus-specific T cells that
can provide the first waves of apoptotic substrates, upon
performing their effector function. This mechanism may be
maintained in patients evolving towards the viral persistence, and
be further amplified by the apoptotic antigen-specific T cells
themselves providing further waves of apoptotic antigens.
Additional studies, even in appropriate experimental models,
are required to ascertain the role of these autoreactive responses
in the chronic evolution of infection. Moreover, it could be of
interest to investigate if an expansion of mucosal associated
invariant type-17 CD8
+ T cells may participate in the high IL-17
production [53], as well as if other additional cytokines including
IL-10 [54] may increase the polyfunctionality of apoptotic
epitope-specific CD8
+ T cells.
IL-17 production can account for the transient intra-hepatic
infiltration of neutrophils found only in the early phase of acute
HCV infection [55]. Then, these responses timely decline likely
through the simultaneous presence of autoreactive type-1, -2, and -
17 CD8
+ TEM cells, which may regulate each other, and even the
capacity of type-17 CD8
+ TEM cells to express a certain degree of
plasticity [15,18,27–29], and to convert to type 1/17 CD8
+ TEM
cells. Therefore, the environmental setting during an acute
inflammatory disease seems to be addressed to guarantee the
coexisting polarization of type-1, -2, -17, -1/17 CD8
+ TEM cells,
and even type-2/17 CD8
+ TEM cells, likely to limit excessive
damage by fine-polarized type-1 or type-17 CD8
+ TEM cells. In
this context, it is intriguing the observation that the polyfuctional
autoreactive CD8
+ T cells express high PD-1 levels in vivo and are
limited only partially by the inhibitory PD-1 capacity in vitro.A
possible explanation of this is that these autoreactive CD8
+ T cells
are primed later and thus submitted to a less prolonged antigenic
stimulation than the virus-specific, that in contrast show a
profound exhaustion in patients with HCV infection [32].
Recently, the persistent antigenic stimulation has been demon-
strated to cause down regulation of T-bet, which results in more
severe exhaustion of virus-specific CD8
+ T cells [56]. However,
the tuning of autoreactive CD8
+ TEM cell functions by PD-1, as
well as the high frequencies of apoptotic epitope-specific CD8
+
TEM cells producing IL-4, may contribute to limit excessive
functional responses over time [19,54,57,58].In support of this
hypothesis, our study in patients with long-term chronic HCV
infection demonstrates that liver-infiltrating CD8
+ TEM cells
specific to apoptotic self-epitopes produce levels of cytokines
significantly lower than patients with acute hepatitis (data not
shown).
An important facet of our findings is that they demonstrate a
link between the TCR avidity of autoreactive CD8
+ T cells and
the difference in the responsiveness of apoptotic epitope-specific
CD8
+ T cells exhibited by patients experiencing chronic infection
and those undergoing infection resolution. The dissociation
kinetics of peptide/HLA-A*0201 pentamer binding to antigen-
specific CD8
+ T cells clearly demonstrated that the t1/2 for
apoptotic epitope-complexed pentamer staining to CD8
+ T cells
from patients experiencing chronic infection was significantly
longer than the decay of pentamer staining from patients
undergoing infection resolution. The t1/2 for pentamer staining
was detected on freshly isolated CD8
+ T cells, suggesting that
TCR avidity measured by this system likely reflects what occurs in
vivo. In the original study, this methodological approach made it
possible to postulate that T cells with TCRs that bind peptide/
MHC complexes for a longer duration are selectively preserved in
comparison to T cells that express TCRs with lower avidity [34].
Recent studies suggested that in response to different microbial
infections, initially naı ¨ve T cells with a wide range of avidity are
efficiently recruited and expanded [59,60]; subsequently, those
with lower avidity undergo premature contraction, whereas those
with higher avidity are selected because of a more prolonged
expansion and correlate with protection [59,60]. Our results
provide an additional challenge to this model, and demonstrate
that the TCR avidity of autoreactive CD8
+ T cells specific for
apoptotic self-epitopes was significantly higher in patients under-
going chronic infection than in those resolving infection. The
selection of the autoreactive CD8
+ T cells with higher avidity likely
occurs because of a sustained stimulation by apoptotic antigens
[8]. By contrast, lower avidity CD8
+ T cells in the presence of
weaker stimuli would undergo rapid contraction, as seen in the
peripheral blood of patients with self-limited HCV infection. The
viral persistence may provide the conditions that influence the
availability of sustained apoptotic antigenic stimuli. However, our
model does not exclude the possibility that cross-reactive CD8
+ T
cells, even expressing dual TCR [61], may intervene in this
process.
Finally, our results may provide an important platform for the
design of innovative therapeutic strategies to re-engineer protec-
tive immune responses in persisting infections. In addition, further
studies will ascertain whether polyfunctional CD8
+ T cells that are
specific to apoptotic epitopes could predict chronic infection in
other acute (i.e., HBV or HIV) infections that develop viral
persistence. The detection of these autoreactive CD8
+ T cells may
also be relevant in determining whether the contraction or the
quality variation of the polyfunctional responses can be used as
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Materials and Methods
Study population
The study cohort included 18HLA-A2
+patients with acute
HCV infection (5 women, 13 men, median age 34 years, range
22–57 years), according to the ethical guidelines of the 1975
Declaration of Helsinki and priori approval by the Ethics
Committee of the Italian National Institute of Health: written
informed consent was obtained from all patients. Diagnosis of
acute HCV infection was based on (1) high levels of serum ALT;
(2) seroconversion assessed by third generation enzyme linked
immunosorbent assay, or anti-HCV positivity at the time of the
diagnosis with an anti-HCV negative test in the previous 12
months; (3) presence of HCV-RNA in at least the first serum
sample, and (4) sudden onset of liver disease symptoms. Alternative
causes of acute hepatitis, such as other viral infection, autoimmu-
nity, alcohol, drugs, and toxins were excluded. Patients with
concomitant immunological disorders or with HIV coinfection
were also excluded from the study.
Cell preparations
PBMCs were isolated and T cell clones were generated as
previously described [64]. CD8
+ T cells were purified from
PBMCs by positive selection coupled to magnetic beads
(MiltenyiBiotec) as previously described [54]. Flow cytometry
analysis demonstrated .99% CD8
+ cells in the positively purified
population and ,5% in the CD8-depleted population. To purify
antigen-specific type-17 CD8
+ cells, PBMCs were stimulated with
the relevant peptide plus anti-CD28 (4 mg/ml) (BD Pharmingen).
Then, cells were stained with allophycocyanin (APC)-labeled anti-
CCR6 (R&D System) and phycoerythin-cyanine 7 (PE-Cy7)-
labeled anti-CCR4 (BD Pharmingen) and processed with FAC-
SAria (Becton Dickinson) to sort CCR6
+CCR4
+ cells: .98% of
these cells both produced IL-17 in response to the relevant peptide
and were susceptible of staining with the relevant pentamers, as
detected below. Spontaneous apoptosis of PBMCs from patients
was determined by staining with Annexin-V (ApoAlert Apoptosis
Kit, Clontech Laboratories Inc), propidium iodide (PI) (Sigma-
Aldrich) and PE-Cy7-labeled anti-CD3 (BD Pharmingen) before
and after 18 h incubation at 37uC. Immature (i)DCs were derived
from peripheral monocytes that had been purified by positive
selection with anti-CD14 mAb coupled to magnetic beads
(MiltenyiBiotec). CD14
+ cells were incubated for 5 days in RPMI
1640 medium containing 5% FCS, 2 mM glutamine, 1%
nonessential amino acids, 1% sodium pyruvate, 50 mg/ml
kanamycin (Gibco BRL), 50 ng/ml rGM-CFS (Novartis Pharma),
and 1000 U/ml rIL-4 (gently provided by A. Lanzavecchia,
Bellinzona, CH). Mature DCs were obtained by a 40-h stimulation
of iDCs with soluble rCD40L molecules (Alexis Biochemicals,
Alexis Corporation). The definition of monocyte-derived DCs was
based on their surface phenotype profile by staining with anti-
CD14, anti-CD86 (Caltag Laboratories), anti-CD1a, anti-CD1c,
anti-CD11c, anti-CD32, anti-CD80 (BD PharMingen) mAbs,
Annexin-V (ApoAlert Apoptosis Kit, Clontech Laboratories Inc),
PI (Sigma-Aldrich), and the appropriate secondary labeled
antibodies (BD PharMingen).
ELISPOT assay ex vivo
Highly purified CD8
+ T cells (1610
5) from PBMCs were
stimulated for 4–6 h with nine independent pools of apoptotic
peptides (Table S1A–C), eight independent pools of viral-peptides
(genotype 1b), eight independent pools of viral-peptides (genotype
2c) [8,25], or nine pools of overlapping peptides spanning the
entire HCV genotype 3a (Chiron Mimotopes) (Table S2A–E),
and irradiated autologous CD8-depleted PBMCs, used as APCs,
and tested by an ELISPOT assay, as described [8]. Each peptide
pool contained 5 mg/ml of each single peptide.
Pentamer staining
PBMCs were incubated with APC-labeled–HLA-A*0201 pen-
tamers (complexed to vimentin78–87 [LLQDSVDFSL], non-
muscle myosin478–486 [QLFNHTMFI], or non-muscle myo-
sin741–749 [VLMIKALEL] peptide) for apoptotic epitopes and
APC-labeled–HLA-A*0201 pentamers (complexed to HCV-
NS31073–1081 [CINGVCWTV], HCV-NS31406–1415 [KLVALGI-
NAV] or HCV-Core132–140 [DLMGYIPAV] peptide) for viral
epitopes (ProImmune Limited, Oxford, United Kingdom), in
FACS buffer (PBS 16, 2% human AB serum) for 10 min at 37uC,
followed by washing and further incubation with APC-Cy7-
labeled mAb to CD8 (BD Pharmingen, San Diego, CA),
fluoresceinisothiocyanate (FITC)-labeled anti-PD-1 (BD Pharmin-
gen), PE-labeled anti-CD127 (BD Pharmingen), FITC-labeled
anti-CD45RO (Caltag Laboratories, Burlingame, CA) for 20 min
at 4uC. Negative controls were obtained by staining cells with an
irrelevant isotype-matched mAb. Cells were washed, acquired
with a FACSCanto flow cytometer and FACSDiva analysis
software (Becton Dickinson) or FlowJo software version 7.5.5
(Tree star, Inc. San Carlos, CA).
Intracellular cytokine staining
PBMCs were stained with pentamers and mAb to CD8, and
then stimulated with or without different concentrations of the
corresponding uncomplexed peptide (ProImmune Limited) plus
anti-CD28 mAb (4 mg/ml) (BD Pharmingen), or with PMA
(50 ng/ml) plus ionomycin (1 mg/ml) (Sigma Aldrich, Milan,
Italy), for 6 h at 37uC. At the 2nd h, 10 mg/ml Brefeldin A (Sigma-
Aldrich) was added. Cells were washed, fixed and permeabilized
using Cytofix/Cytoperm solution (BD Pharmingen) at 4uC for
20 min, re-washed with Perm Wash Buffer (BD Pharmingen), and
intracellularly stained with different combinations of Alexa Fluor
488-labeled anti-IL17A (eBioscience San Diego, CA), PE-labeled
anti-IFN-c, PE-labeled anti-IL-2, FITC-labeled anti-IL-4 (BD
Pharmingen), PE-labeled anti-RORC (eBioscience) or purified
anti-T-bet (Santa Cruz Biotechnology Santa Cruz, California) for
30 min at 4uC. When stained with unlabeled specific antibody to
detect T-bet, cells were washed and stained with the appropriate
secondary FITC-labeled antibody. Cells were washed, acquired
with a FACSCanto flow cytometer and FACSDiva analysis
software (Becton Dickinson) or FlowJo software (Tree star).
Cross-presentation of apoptotic cells
Cloned CD8
+CD95
+ T cells (10–100610
6) were incubated in
the presence or absence of 14 mg/ml C3I (Z-DEVD-FMK), or a
negative caspase control (K, Z-FA-FMK) (BD Pharmingen) for 1 h
at 37uC in a 24-well plate. Then, cells were induced to apoptosis
by incubation with 500 ng/ml anti-Fas (anti-CD95 mAb [clone
CH11], Upstate Biotechnology) for at least 6 h. Apoptotic cells
were determined by staining with Annexin-V (ApoAlert Apoptosis
Kit, Clontech Laboratories Inc), PI (Sigma-Aldrich) and flow-
cytometry analysis. PBMCs were double-stained with pentamers
and mAb to CD8 and cultured with iDCs that had been pulsed or
not with apoptotic cloned T cells. After 6–8 h, cells were tested for
their capacity to produce IL-17 and IFN-c by ICS as described
above. Cells were washed, acquired with a FACSCanto flow
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Dickinson) or FlowJo software (Treestar).
Pentamer staining decay (dissociation kinetics)
PBMCs were stained with saturating amounts of APC-labeled-
HLA-A*0201 pentamers and APC-Cy7-labeled-CD8 (BD Phar-
mingen) for 45 min at room temperature [34]. Then, cells were
washed three times with buffer (2% FCS, 0.01 sodium azide in
PBS) and resuspended in 500 ml of buffer with saturanting
amounts of mAb to HLA-A2 (BB7.2, ATCC). At various time
points (0, 30 min, 1 h, 2 h and 3 h), an aliquot cells was washed
and the fluorescence intensity was determined by flow cytometry
analysis. Double staining using an anti-human TCRa/b (BD
Pharmingen) and pentamers was performed in parallel to
normalize pentamer fluorescence against the expressed TCR.
The values were then normalized to percent of the total
fluorescence at the initial time point and plotted on a logarithmic
scale. t1/2 are determined by calculating the (ln2)/mean slope
value of plots of the natural logarithm (ln) of the pentamer
fluorescence normalized for the TCR fluorescence. The slope is
equivalent to ln(Fa/Fb)/t, where Fa is the normalized fluorescence
at the start of the interval, Fb is the normalized fluorescence at the
end of the interval, and t is the length of the interval (minutes).
T cell polarization
PBMCs were incubated for 10 days at 37uC with specific
peptides (apoptotic or viral peptides), human rIL-6 (50 ng/ml),
rIL-1b (10 ng/ml), rIL-23 (50 ng/ml) and rTGF-b (10 ng/ml)
(R&D Systems) for the Th17 cell polarization. For the Th1 cell
polarizing condition, PBMCs were antigen-stimulated in the
presence of recombinant human rIL-12 (10 ng/ml) and rIFN-c
(100 U/ml) (R&D Systems). Recombinant IL-2 was added on day
4 of culture (50 U/ml). On day 10, cells were stained with surface
antibodies, pentamers, anti-IL-17A, anti-IFN-c, anti-IL-2 and
anti-IL-4 mAbs. Cells were washed, acquired with a FACSCanto
flow cytometer and analyzed with FACSDiva analysis software
(Becton Dickinson) or FlowJo software (Tree star).
Statistical analysis
All statistical analyses were performed with Prism 4 (GraphPad)
software using nonparametric Spearman’s correlation test, non-
parametric Mann-Whitney U-test for unpaired data and Wilcoxon
test for paired data. The differences were considered significant at
P,0.05.
Accession numbers
actin cytoplasmic 1 [ACTB] P60709
heterogeneous nuclear ribonucleoprotein [ROK] P61978
lamin B1 [LAM1] P20700
non muscle myosin heavy chain 9 [MYH9] P35579
vimentin [VIME] P08670
proteasome component C2 [PSA1] P25786
Supporting Information
Figure S1 Effector CD8
+T cells specific to apoptotic or
viral epitopes in patients with acute HCV infection. Fresh
CD8
+T cells, purified from PBMCs of HLA-A2
+patients under-
going chronic or self-limited HCV infection, were able to form
IFN-c spots promptly within 6 h of contact with autologous
irradiated CD8-depleted PBMCs, as APCs, plus peptide ex vivo,a s
detected by an ELISPOT assay. Because of the limited number of
PBMCs obtained from patients, freshly isolated CD8
+T cells were
tested against: 9 pools of apoptotic epitopes (see Table S1A–C), 8
pools of HLA-A2-binding peptides of HCV genotype 1c or
genotype 2c, 9 pools of overlapping peptides spanning the entire
HCV genotype 3a (see Table S2A–E). Each patient was studied
with the viral peptides matched the own infecting genotype (see
Table 1). Results are expressed as the number of peptide pools
recognized in ELISPOT. Bars represent mean 6 SD. P values
have been calculated by comparing the number of recognized
peptide pool in patients with chronic or resolved HCV infection at
each time point.
(TIF)
Figure S2 Polyfunctional CD8
+ TEM cells specific to
apoptotic epitopes in patients with acute HCV infection.
Percentage of cells producing the indicated cytokines in
CD8
+pentamer
+ cells in response to the indicated apoptotic
epitopes (evaluated at the indicated time points by flow cytometry
analyses) from patients with acute HCV infection experiencing
chronic infection (filled symbols) or undergoing infection resolu-
tion (empty symbols). Circle symbols represent MYH9478–485
pentamer specificity, square symbols represent MYH9741–749
pentamer specificity, and triangle symbols represent VIME78–87
pentamer specificity. The horizontal dashed line delimits an
arbitrary background, which is based on the values of 20 HLA-
A2
+ healthy individuals exhibiting ,0.1% cytokine-producing
cells in gated CD8
+pentamer
+ cells in each test.
(TIF)
Figure S3 Polyfunctional CD8
+ TEM cells specific to viral
epitopes in patients with acute HCV infection. Percentage
of cells producing the indicated cytokines in CD8
+pentamer
+ cells
in response to the indicated viral epitopes (evaluated at the
indicated time points by flow cytometry analyses) from patients
with acute HCV infection experiencing chronic infection (filled
symbols) or undergoing infection resolution (empty symbols). The
horizontal dashed line delimits an arbitrary background, which is
based on the values of 20 HLA-A2
+ healthy individuals exhibiting
,0.1% cytokine-producing cells in gated CD8
+pentamer
+ cells in
each test. Circle symbols represent HCV-NS31073–1081 pentamer
specificity, square symbols represent HCV-NS31406–1415 pentamer
specificity, and triangle symbols represent HCV-Core132–140
pentamer specificity. NS=not significant.
(TIF)
Figure S4 Mixed polyfunctional apoptotic epitope- or
viral epitope-specific CD8+ T cell responses. Number of
patients exhibiting a wide repertoire of polyfunctional CD8
+ T
cells producing one or two cytokines in response to apoptotic (A)o r
viral (B) epitopes.
(TIF)
Figure S5 Kinetics of fresh IFN-c-producing CD8
+ T
cells specific to apoptotic epitopes. PBMCs isolated from
patients with acute HCV infection at the different time points
indicated were stained with mAb to CD8 and pentamers
complexed with the indicated apoptotic peptide. Cells were
stimulated with the relevant soluble peptides plus anti-CD28
mAb for 6 h and then processed for the detection of IL-17 and
IFN-c by ICS assay with the relevant mAbs. Counterplot analyses
are gated on CD8
+pentamer
+ cells and show percentages of
cytokine-producing cells. The percentage of cells is reported in
each quadrant.
(TIFF)
Figure S6 No intrinsic defect of effector functions in
CD8
+ T cells from patients with acute HCV infection. (A)
One representative flow cytometry analysis in which PBMCs from
patients with acute HCV infection were stained with mAb to CD8
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PLoS Pathogens | www.plospathogens.org 14 June 2012 | Volume 8 | Issue 6 | e1002759and the indicated pentamer, stimulated with PMA and iono for
6 h, and processed for the detection of the indicated cytokines by
ICS assay with the relevant mAbs. Counterplot analyses are gated
on CD8
+pentamer
+ cells and show percentages of cytokine-
producing cells. The percentage of cells is reported in each
quadrant. (B) Percentage of cells producing the indicated cytokines
in CD8
+pentamer
+ cells in response to PMA and iono (evaluated
at the indicated time points by flow cytometry analyses) from
patients with acute HCV infection experiencing chronic infection
(filled symbols) or undergoing infection resolution (empty symbols).
(TIF)
Figure S7 Naı ¨ve, central, and effector memory CD8
+ T
cells specific to apoptotic or viral epitopes. (A) One
representative flow cytometry analysis, the values of the total
patients are shown in (B), in which PBMCs from a patient with
acute HCV infection were stained with mAbs to CD8, CD45RO,
and CD127 and with the pentamer complexed with the indicated
apoptotic peptide. Counterplot analyses are gated on CD8
+penta-
mer
+ cells and show percentages of CD45RO
+ and/or CD127
+
cells. The percentage of cells is reported in each quadrant. (B)
Percentages of CD45RO
+CD127
2, CD45RO
2CD127
+,o r
CD45RO
+CD127
+ cells in CD8
+pentamer
+ cells from aHCV
patients experiencing chronic infection (filled circles) or infection
resolution (empty circles). (C) One representative of six flow
cytometry analyses in which PBMCs from a patient with acute
HCV infection were stained with mAbs to CD8 and CD127 and
with the pentamer complexed with the indicated peptide. Cells
were stimulated with the same soluble peptide for 6 h and then
processed for the detection of the indicated cytokines by ICS assay
with the relevant mAbs.
(TIFF)
Figure S8 PD-1 expression in CD8
+ T cells specific to
apoptotic or viral epitopes. (A,B) Percentage of PD1
+ cells in
apoptotic (A) or viral (B) epitope-specific CD8
+pentamer
+ cells
from patients with acute HCV infection experiencing chronic
infection (filled circles) or undergoing infection resolution (empty
circles). PBMCs, isolated at the different time points indicated,
were stained with mAbs to CD8 and PD-1 and with pentamers
complexed with the indicated peptides. In the panel A, circle
symbols represent MYH9478–485 pentamer specificity, square
symbols represent MYH9741–749 pentamer specificity, and triangle
symbols represent VIME78–87 pentamer specificity. In the panel B,
circle symbols represent HCV-NS31073–1081 pentamer specificity,
square symbols represent HCV-NS31406–1415 pentamer specificity,
and triangle symbols represent HCV-Core132–140 pentamer
specificity. NS=not significant.
(TIFF)
Figure S9 CD8
+ T cells specific to apoptotic epitopes are
accumulated in the liver from patients with long-term
chronic HCV infection. Representative flow cytometry anal-
yses of PBMCs or intra-hepatic lymphocytes (IHLs) isolated from a
liver biopsy of a HLA-A2
+ patient with chronic HCV infection.
Cells were double-stained with a mAb to CD8 and pentamers
expressing the indicated peptide of MYH9. Analyses show the
percentage of CD8
+pentamer
+ cells.
(TIFF)
Table S1 HLA-A2 binding peptides derived from apo-
ptotic cell-associated proteins appearing with their
cleavage products in proteomic analysis.
(PDF)
Table S2 Peptides derived from HCV (Genotype 1b,
Genotype 2c, or Genotype 3a) proteins used for the
recognition by CD8
+ T cells. (A,B)HLA-A2 binding peptides
derived from HCV Genotype 1b, or (C,D)HCV (Genotype 2c)
proteins potentially recognized by HLA-A2-restricted HCV-
specific CD8
+ T cells. (E) Overlapping peptides spanning the
entire HCV Genotype 3apotentially recognized by all HLA-
restricted HCV-specific CD8
+ T cells.
(PDF)
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